​

Sionna Therapeutics Stock (NASDAQ:SION)

OwnershipFinancialsChart
Sionna Therapeutics by TradingView

Previous Close

$39.21

52W Range

$7.25 - $43.20

50D Avg

$27.57

200D Avg

$18.84

Market Cap

$1.69B

Avg Vol (3M)

$282.53K

Beta

3.45

Div Yield

-

SION Company Profile

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

41

IPO Date

Feb 07, 2025

Website

SION Performance

SION Financial Summary

Dec 24Dec 23Dec 22
Revenue---
Operating Income$-70.56M$-50.33M$-41.37M
Net Income$-61.69M$-47.26M$-40.24M
EBITDA$-69.89M$-49.75M$-41.25M
Basic EPS$-1.45$-1.70$-2.32
Diluted EPS$-15.99$-1.70$-2.32

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
MAZEMaze Therapeutics, Inc.
IMTXImmatics N.V.
AMLXAmylyx Pharmaceuticals, Inc.
ATAIAtai Life Sciences N.V.
SYRESpyre Therapeutics, Inc.
NBTXNanobiotix S.A.
TSHATaysha Gene Therapies, Inc.
ZYMEZymeworks Inc.
ORICORIC Pharmaceuticals, Inc.
TRVITrevi Therapeutics, Inc.